Ravi Vij Selected Research

Ravi Vij Research Topics

Disease

115	Multiple Myeloma 04/2024 - 11/2006
33	Neoplasms (Cancer) 04/2024 - 07/2008
32	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 07/2006
22	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2022 - 07/2006
14	Leukemia 01/2021 - 07/2009
12	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2023 - 01/2006
11	Disease Progression 03/2023 - 10/2009
8	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2021 - 11/2004
5	Infections 01/2022 - 06/2008
5	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 01/2009
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 01/2016
3	Viremia 01/2022 - 03/2003
3	Lymphoma (Lymphomas) 01/2021 - 12/2016
3	Pathologic Complete Response 01/2020 - 10/2015
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2020 - 04/2012
3	Genetic Translocation (Chromosomal Translocation) 01/2018 - 08/2012
3	Hematologic Neoplasms (Hematological Malignancy) 08/2017 - 08/2008
3	Anemia 08/2017 - 10/2007
2	Venous Thromboembolism 11/2023 - 11/2023
2	Cytokine Release Syndrome 03/2023 - 10/2016
2	Inflammation (Inflammations) 01/2021 - 06/2016
2	Pneumonia (Pneumonitis) 01/2020 - 01/2017
2	Dyspnea (Shortness of Breath) 01/2020 - 11/2013
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2019 - 06/2016
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 12/2015
2	Hypoxia (Hypoxemia) 12/2017 - 04/2016
2	Neutropenia 09/2017 - 10/2007
2	Thrombocytopenia (Thrombopenia) 09/2017 - 06/2016
2	Bronchiolitis Obliterans Syndrome 04/2017 - 10/2007
2	Myeloid Leukemia (Leukemia, Myelocytic) 04/2017 - 04/2014
2	Hodgkin Disease (Hodgkin's Disease) 12/2016 - 11/2011
2	Vomiting 06/2016 - 06/2008
2	Nausea 06/2016 - 06/2008
2	Residual Neoplasm 01/2016 - 10/2015
2	Peripheral Nervous System Diseases (PNS Diseases) 10/2012 - 06/2012
2	Amyloidosis 02/2009 - 06/2003
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 01/2023

Drug/Important Bio-Agent (IBA)

29	Lenalidomide (CC 5013)FDA Link 11/2023 - 01/2009
24	Dexamethasone (Maxidex)FDA LinkGeneric 12/2023 - 06/2012
23	carfilzomibIBA 11/2023 - 06/2011
22	Bortezomib (Velcade)FDA Link 11/2023 - 11/2007
15	Proteasome InhibitorsIBA 03/2023 - 11/2011
10	Monoclonal AntibodiesIBA 01/2022 - 03/2016
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 07/2006
6	daratumumabIBA 03/2023 - 01/2018
6	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023 - 03/2003
6	Azacitidine (5 Azacytidine)FDA Link 01/2021 - 09/2009
5	elotuzumabIBA 12/2023 - 06/2012
5	Immunomodulating AgentsIBA 03/2023 - 11/2011
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2013
5	isatuximabIBA 12/2021 - 01/2017
5	selinexorIBA 09/2021 - 01/2018
5	plerixafor FDA Link 01/2021 - 08/2008
5	Thalidomide (Thalomid)FDA Link 07/2012 - 08/2009
4	pomalidomideIBA 12/2023 - 02/2014
4	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2021
4	Melphalan (Alkeran)FDA LinkGeneric 01/2021 - 06/2003
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 11/2009
4	Decitabine FDA Link 12/2017 - 09/2011
3	B-Cell Maturation AntigenIBA 03/2023 - 01/2022
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 04/2012
3	Calcineurin InhibitorsIBA 01/2019 - 01/2015
3	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2018 - 04/2014
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 04/2016
3	CreatinineIBA 06/2016 - 11/2013
3	vatalanib (PTK787)IBA 11/2014 - 08/2010
2	idecabtagene vicleucelIBA 04/2024 - 03/2023
2	Transcription Factors (Transcription Factor)IBA 11/2023 - 12/2017
2	Chimeric Antigen ReceptorsIBA 03/2023 - 01/2022
2	EpitopesIBA 10/2022 - 01/2020
2	PENTAIBA 09/2021 - 05/2020
2	AntigensIBA 01/2021 - 01/2017
2	Bendamustine Hydrochloride FDA Link 05/2020 - 12/2015
2	Filgrastim (Neupogen)FDA Link 01/2020 - 12/2017
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2019 - 01/2017
2	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 07/2006
2	liposomal doxorubicin (Doxil)FDA Link 01/2019 - 11/2011
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 07/2006
2	Denosumab FDA Link 05/2018 - 10/2009
2	Rituximab (Mabthera)FDA Link 12/2015 - 11/2004
2	Clofarabine (Clolar)FDA Link 05/2014 - 11/2006
2	Gemtuzumab (Mylotarg)FDA Link 03/2011 - 11/2009
2	DNA (Deoxyribonucleic Acid)IBA 02/2009 - 06/2008
1	fibrin fragment D (D-dimer)IBA 11/2023
1	ChromatinIBA 11/2023
1	TransposasesIBA 11/2023
1	Tumor Biomarkers (Tumor Markers)IBA 01/2023

Therapy/Procedure

57	Therapeutics 03/2023 - 08/2009
25	Cell Transplantation 12/2023 - 08/2011
18	Transplantation 01/2023 - 03/2003
15	Drug Therapy (Chemotherapy) 01/2021 - 07/2008
14	Stem Cell Transplantation 11/2020 - 11/2004
10	Autologous Transplantation 12/2023 - 06/2003
9	Hematopoietic Stem Cell Transplantation 01/2023 - 05/2012
9	Homologous Transplantation 04/2021 - 07/2006
6	Immunotherapy 01/2022 - 01/2016
4	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 07/2008 - 03/2003
3	Salvage Therapy 12/2023 - 11/2009
3	Hematopoietic Stem Cell Mobilization 10/2019 - 11/2004
2	Duration of Therapy 01/2023 - 01/2019